Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 0 | 0 | 0 | 0 | 1,500 |
| Gross Profit | N/A | N/A | N/A | 0 | 1,500 |
| Operating Expenses | 5,007 | 4,701 | 4,040 | 4,201 | 2,680 |
| Operating Income | -5,007 | -4,701 | -4,040 | -4,201 | -1,180 |
| Other Income | 493 | 532 | 548 | 495 | 296 |
| Pre-tax Income | -4,514 | -4,169 | -3,492 | -3,706 | -884 |
| Income Tax | N/A | N/A | N/A | N/A | 75 |
| Net Income Continuous | -4,514 | -4,169 | -3,492 | -3,706 | -959 |
| Net Income | $-4,514 | $-4,169 | $-3,492 | $-3,706 | $-959 |
| EPS Basic Total Ops | -37.80 | -36.00 | -30.60 | -27.00 | -9.00 |
| EPS Basic Continuous Ops | -38.46 | -35.53 | -29.81 | -27.63 | -8.24 |
| EPS Diluted Total Ops | -37.80 | -36.00 | -30.60 | -27.00 | -9.00 |
| EPS Diluted Continuous Ops | -38.46 | -35.53 | -29.81 | -27.63 | -8.24 |
| EBITDA(a) | $-4,876 | $-4,868 | $-4,070 | $-4,138 | $-1,114 |